top of page
  • Provia Laboratories

Provia Laboratories Bio-Banking Technology Achieves First Patent Approval

Market Research & Private Equity company Grace Century, along with their partner Provia Laboratories LLC, have announced Provia's first ever patent. The newly patented technology will improve stored bio-specimen integrity for future use in research & diagnostic medicine, furthering the fields of bio-banking & personalized medicine.


RAS AL KHAIMAH, United Arab Emirates, June 15, 2015 /PRNewswire/ -- Grace Century's bio-banking project, Provia Laboratories LLC, has announced Provia's first ever patent.

Provia, who specialize in cutting-edge bio-banking products, announced the patent which is entitled "Cryopreservation Device with Retrofitted Electronic Tracking Device". The newly-developed technology will have significant benefits in terms of monitoring the movement, temperature and tracking of stored bio-specimens and their associated data over their lifetime, which ultimately increases the reliability and integrity of bio-specimens.

The banking and future use of bio-specimens is an important aspect of "personalized medicine", a growing scientific field which is being increasingly employed for selecting the most suitable treatments based on the genetic or molecular information from the individual being treated. The chances of a treatment for an illness being successful are generally higher using a personalized medicine approach compared to using a traditional broad-brush approach, where the treatment given for an illness is based on what has been successful for large sample groups rather than the individual being treated.

Provia Chief Executive, Howard Greenman commented, "This patent represents the next generation of our Proviasette storage container technology used for optimized bio-banking of frozen tissue bio-specimens. The patent covers the use of an electronic tracking device fitted to the storage container which can hold samples, such as extremely valuable tumors frequently collected and stored for vital oncology research."

Scott Wolf, CEO of Grace Century also stated, "We have been impressed from the beginning of our association with Provia and their obvious commitment to quality. In our belief, their technology represents nothing less that should be acceptable in this field of research, and this patent is a testament to their commitment."Today, nearly 40 institutions, covering the Pharmaceutical, Biotechnology, Medical and Government sectors use the Provia's Proviasette storage container technology.

About Grace Century, FZ LLC

Grace Century, FZ LLC an International research and private equity consultancy located in Ras Al Khaimah, (north of Dubai) in the United Arab Emirates (UAE). Grace Century specializes in "game-changing" life science and health related private equity projects. For portfolio or company information please email or call +971 (0)7 206 8851. Please direct all media enquiries to or call +971 (0)52 712 1777.

About Provia Laboratories, LLC

Headquartered in Littleton, MA, Provia Laboratories, LLC is a healthcare services company specializing in high-quality bio-banking (the collection, transport, processing and cryogenic storage of biological specimens). Provia Labs offers the Proviasette™ product range for use in bio-banking environments to improve sample logistics, security and quality.

The company manages and promotes its own bio-bank for a dental stem cell banking service, Store-A-Tooth™, which gives families the option to store stem cells to protect their children's future health and take advantage of advances in stem cell therapies.Provia advises industrial, academic and governmental clients on matters related to the preservation of biological specimens for research and clinical use.

Provia Labs is a member of ISBER, the International Society for Biological and Environmental Repositories, as well as ESBB, the European, Middle Eastern & African Society for Bio-preservation & Bio-banking. For further information about Proviasette™, please call Provia Labs at +1 (781) 652-4815, email, or visit Source:

27 views0 comments
bottom of page